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Introduction: Microtubule-actin crosslinking factor 1 (MACF1) is a key cytoskeletal
linker and plays a critical role in numerous cells [1]. We have previously demon-
strated MACF1 to be highly expressed in osteoblastic cells and participated in
the osteoblasts response to environmental stimuli [2]. However, the role of
MACF1 in osteoblast function is not well understood. Studies show that MACF1 is
critical for embryo development by activating Wnt/b-catenin signalling, which
also plays a key role in regulating osteoblast differentiation. We therefore aimed
to investigate whether MACF1 regulates osteoblast differentiation through Wnt/b-
catenin signalling in this study.
Subjects and Methods: Stable MACF1-knockdown MC3T3-E1 preosteoblasts con-
structed by lentivirus-mediated short-hairpin RNA (shRNA) targeting MACF1 gene
were adopted. The MC3T3-E1 preosteoblasts infected by control-shRNA were
used as a control. Alizarin red s staining was applied to detect mineralised nodules
formation. Real time PCR was used to detect the mRNA expression of alkaline
phosphatase (ALP), runt-related transcription factor 2 (Runx2), and T-cell factor
1 (TCF1). The luciferase reporter assay was further used to detect the TCF1 tran-
scriptional activity. Moreover, the b-catenin and GSK-3b levels were measured by
western blot with and without lithium chloride treatment.
Results: MACF1-knockdown (MACF1-KD) significantly inhibited mineralised nodules
formation and osteogenic gene expression. The translocation of b-catenin into the
nucleus was decreased by MACF1-knockdown and the downstream TCF1 transcrip-
tional activity and Runx2 expression were significantly suppressed. However, 6
hour treatment of 30mMLiCl inhibitedGSK-3b activation, induced b-catenin nuclear
translocation and partly restored the decreased expression of TCF1 and Runx2.
These findings showed that MACF1 deficiency inhibited osteoblast differentiation
and the nuclear translocation of b-catenin, suggesting that MACF1 positively regu-
lates osteoblast differentiation and may act through GSK3b/b-catenin signalling.
Discussion and Conclusion: The present study uncovers, for the first time an
important role of MACF1 in osteoblasts and suggests that MACF1 may positively
regulate osteoblast differentiation via b-catenin/TCF1-Runx2 signalling and acts
upstream of GSK-3b/b-catenin signalling.
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Background and objective: Osteosarcoma is the most common primary malig-
nancy of bone. Abnormal expression and activation of the receptor tyrosine ki-
nases (RTKs) play a vital role in the occurrence and development of
osteosarcoma. Studies show that c-Kit, a type III RTK, which is activated by itsligand, stem cell factor (SCF), and the newly-identified signalling mediator Gai
were both over-expressed in human OS tissues and cell line. The two also formed
a signalling complex. Further studies showed that c-Kit-Gai recruited the adaptor
protein Gab1 (Grb2-associated binder 1) to transduce downstream signalling. This
study was designed from a perspective of signalling pathway to investigate the role
of c-Kit-Gai complex in the proliferation of osteosarcoma.
Methods: The expression of Gai1/3, c-kit, and Gab1 of OS cell lines (U2OS, MG-63),
osteoblasts (MC3TC-E1), and bone cells (OB-6) were detected by western blot.
MG63 cells were incubated with 0, 0.1, 1, 5, 25, and 50ng/ml of SCF for 24 and
48 hours. The cell proliferation was detected by Brdu method and the cell survival
was detected by MTT. The MG63 cells were cultured with 50ng/ml SCF for 0, 5, 10,
20, and 30 minutes, western blot was used to detect the expression of T- Kit, P-Kit,
T-Gab1, P-Gab1, T-AKT, Akt473, P-S6K, P-PLC, T-PLC, T-S6, P-S6, T-ERK, and P-
ERK. We used the shRNA-mediated silencing or genetic knockout of Gai in the
MG-63 cells, and further detection of the activation conditions of Akt-mTOR and
Erk-MAPK downstream signalling (T-AKT, Akt473, Akt308, GSK3a/3b, mTOR, S6K,
S6, ERK) in the cells induced by SCF.
Results: The expression of c-Kit, Gai1/3, and Gab1 in cultured OS cell lines (U2OS,
MG-63) was significantly higher than those of osteoblasts (MC3TC-E1) and bone
cells (OB-6). In MG-63 cells, the exogenous SCF increased the phosphorylation of
c-Kit, Gab1, Akt473, S6K, PLC, S6, and ERK, activated signalling pathways, and
then promoted cell proliferation and survival. shRNA-mediated silencing or genetic
knockout of Gai dramatically inhibited the phosphorylation of Akt473, Akt308,
GSK3a/3b, mTOR, S6K, S6, and ERK, which was activated by SCF.
Conclusion: The c-Kit-Gai complex transduces Akt-mTOR and Erk-MAPK down-
stream signalling activated by SCF, and then plays a key role in maintaining and
promoting the survival and proliferation of osteosarcoma cells. The target therapy
aimed at the complex will provide a new approach to curb and treat osteosarcoma.
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Introduction: Osteosarcoma (OS) is the most frequent primary bone sarcoma,
which is generally regarded as a differentiation disease that is caused by genetic
and epigenetic disruptions of terminal differentiation of osteoblasts. Bone
morphogenetic protein 9(BMP9) is probably the most osteogenic differentiation
potent inducer, but whether it can induce osteogenic differentiation of OS is un-
clear. All-trans retinoic acid (ATRA) can restore normal osteogenesis in OS. In
this study, we aim to identify the relationship between ATRA and BMP9 in inducing
osteogenesis differentiation of OS.
Subjects and Methods: 143B, OS cell line, were used to explore the mechanisms of
regulating differentiation and proliferation during treatment with ATRA and (or)
BMP9. The level of protein expression was tested by western blot assay. The levels
of mRNA expression were tested by Semi-quantitative RT-PCR (sqPCR). ALP activity
was assessed by a modified Great Escape SEAP Chemiluminescence assay. The pro-
liferation effects were tested by crystal violet staining.
Results: In 143B cells, BMP9 could not up-regulate the expression of osteogenesis
markers (such as Runx-2, Dlx-5, ALP, OPN, and OCN) but conversely, it could promote
proliferationof cells. Then,we found thatATRA successfully enhanced thesemarkers,
and it significantly inhibited proliferation of cells. The expression levels of BMP9were
up-regulated after ATRA treatment. Cells stimulated by treating with ATRA and BMP9
exhibited higher expression levels of osteogenesismarkers, than that treated byATRA
or BMP9, and also the effect of anti-proliferation of ATRA was enhanced. During dif-
ferentiation induction, the expression level of P-p38 was up-regulated with ATRA
treatment, which was higher than that with ATRA or BMP9 treatment. The osteogen-
esis markers induced by ATRA or ATRA and BMP9, were down-regulated by treated
with SB (p38 inhibitor SB203580). Meanwhile, SB could promote the proliferation of
143B cells; it also reversed the anti-proliferation of ATRA.
Discussion and Conclusion: According to the results of all above, we find that BMP9
fails to induce osteogenic differentiation of 143B cells alone, which is inconsistent
with the previous report that BMP2 can promote differentiation of OS, indicating
the existence of possible differentiation of BMP9 defects in OS. We found that ATRA
successfully induces osteoblastic differentiation of osteosarcoma cells in vitro and
it significantly inhibited proliferation of 143B cells, which is consistent with other re-
ports. Meanwhile, ATRA up-regulated the expression levels of BMP9 inOS. The expres-
sion levels of osteogenic-related genes were enhanced when BMP9 combined with
ATRA. Thus, we suppose that in the osteogenic potential restoration of BMP9 in OS,
ATRAmay play a critical role. During differentiation induction, the p38MAPK pathway
mayhavean important role in the control of osteogenesis-related genes expression. In
conclusion, this studydemonstrates thatATRAcanrestore theosteogeniccapabilityof
